Letters to the Editor

Ibrutinib versus acalabrutinib in fixed-duration chronic lymphocytic leukemia therapy: a comparative analysis of efficacy

Department of Hematology, Hull University Teaching Hospitals NHS Trust, Hull
Department of Medicine, Stanford University, Stanford CA
Biostatistics Unit, Scientific Directorate Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome
Department of Hematology, Hull University Teaching Hospitals NHS Trust, Hull, UK; Centre for Biomedicine, Hull York Medical School, Hull
Haematologica Early view Jul 3, 2025 https://doi.org/10.3324/haematol.2025.288323